|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 氯吡格雷加依替巴肽抑制血小板反应性:氯吡格雷加依替巴肽抑制血小板反应性(CLEARPlatelets)研究结果 | Gurbel P.A. Bliden K.P. Zaman K.A. 张迎捷 | 2005 | 世界核心医学期刊文摘(心脏病学分册)2005，0，9： | 28 |
| 2 | Increased Risk in Patients With High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention显示文摘 | Kevin P. Bliden Joseph DiChiara Udaya S. Tantry Ashwani K. Bassi Srivasavi K. Chaganti Paul A. Gurbel | 2007 | Journal of the American College of Cardiology2007，，6： | 2 |
| 3 | Erythropoietin therapy after out-of-hospital cardiac arrest:A systematic review and meta-analysis显示文摘AIM To assess safety and efficacy of early erythropoietin(Epo) administration in patients with out-of-hospital cardiac arrest(OHCA).METHODS A systematic literature search was performed using PubM ed,MEDLINE,EMBASE,EBSCO,CINAHL,Web of Science and Cochrane databases,of all studies published from the inception through October 10,2016.Inclusion criteria included:(1) Adult humans with OHCA and successful sustained return of spontaneous circulation;and(2) studies including mortality/brain death,acute thrombotic events as their end points.Primary efficacyoutcome was 'brain death or Cerebral Performance Category(CPC) score of 5'.Secondary outcomes were 'CPC score 1,and 2-4','overall thrombotic events' and 'acute coronary stent thrombosis'.RESULTS We analyzed a total of 606 participants(n = 276 received Epo and n = 330 with standard of care alone) who experienced OHCA enrolled in 3 clinical trials.No significant difference was observed between the Epo and no Epo group in brain death or CPC score 5(OR = 0.77;95%CI:0.42-1.39),CPC score 1(OR = 1.16,95%CI:0.82-1.64),and CPC score 2-4(OR = 0.77,95%CI:0.44-1.36).Epo group was associated with increased thrombotic complications(OR = 2.41,95%CI:1.26-4.62) and acute coronary stent thrombosis(OR = 8.16,95%CI:1.39-47.99).No publication bias was observed.CONCLUSION Our study demonstrates no improvement in neurological outcomes and increased incidence of thrombotic events and acute coronary stent thrombosis in OHCA patients who were treated with Epo in addition to standard therapy. | Rahul Chaudhary Jalaj Garg Parasuram Krishnamoorthy Kevin Bliden Neeraj Shah Nayan Agarwal Rahul Gupta Abhishek Sharma Karl B Kern Nainesh C Patel Paul Gurbel | 2017 | World Journal of Cardiology2017，9，12： | 2 |
| 4 | Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis显示文摘 | Paul A. Gurbel Kevin P. Bliden Waiel Samara Jason A. Yoho Kevin Hayes Mulugeta Z. Fissha Udaya S. Tantry | 2005 | Journal of the American College of Cardiology2005，，10： | 2 |
| 5 | Failure of clopidogrel to reduce platelet reactivity and activaton following standard doing inelective stenting: implications for thrombotic events and restenosis 显示文摘 | Paul AG Samara WM Bliden KP | 2004 | Platelets2004，15，： | 1 |
| 6 | The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies显示文摘 | BLIDEN K P TANTRY U S STOREY R F | 2011 | Am Heart J2011，162，1： | 1 |
| 7 | Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing PCI:is the current antiplatelet therapy adequate显示文摘 | Bliden KP DiChiara J Tantry US | 2007 | J Am Coll Cardiol2007，49，6： | 1 |
| 8 | Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of elopidogrel therapy 显示文摘 | Shuldiner AR O'Connell JR Bliden KP | 2009 | JAM A2009，302，8： | 1 |
| 9 | Antiplatelet thera- py:current strategies and future trends显示文摘 | Tantry US Etherington A Bliden KP | 2006 | Future Cardiol2006，2，3： | 1 |
| 10 | et al regarding article,' administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coro- nary syndrome'显示文摘 | GURBEL P A BLIDEN K P TANTRY U S | 2014 | CircCardiovasc Interv2014，7，2： | 1 |
| 11 | The difference between clo- pidogrel responsiveness and posttreatment platelet reactivity 显示文摘 | Samara WM Bliden KP Tantry US | 2005 | Thromb Res2005，115，12： | 1 |
| 12 | Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study显示文摘 | GURBEL P A BLIDEN K P BUTLER K | 2009 | Circulation2009，120，25： | 1 |
| 13 | Bivalirudin and clopi- dogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 ( Clo- pidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study 显示文摘 | Gurbel PA Bliden KP Sancedo JF | 2009 | J Am Coil Cardiol2009，24，53： | 1 |
| 14 | Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel- associated bleeding related to CABG (TARGET-CABG) study 显示文摘 | Mahla E Suarez TA Bliden KP | 2012 | Circ Cardiovase Interv2012，5，2： | 1 |
| 15 | Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease the ONSET/OFFSET study显示文摘 | Gurbel PA Bliden KP Butler K | 2009 | Circulation2009，，120： | 1 |
| 16 | Clopidogrel loading with eptifibatide to arrest the reactivity of platelets study 显示文摘 | Gurhel PA Bliden KP Zaman KA | 2005 | Circula- tion2005，111，9： | 1 |
| 17 | ClopidogTel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity 显示文摘 | Paul A Bliden KP Hiatt BL | 2003 | Circulation2003，107，： | 1 |
| 18 | Evaluation of doserelated effects of aspirin on platelet function:results from the Aspirin-Induced Platelet Effect (ASPECT) study显示文摘 | Gurbel PA Bliden KP DiChiara J | | 0，，： | 1 |
| 19 | Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pre- treatment platelet reactivity 显示文摘 | Gurbel PA Bliden KP Hiatt BL | 2003 | Circulation2003，107，23： | 1 |
| 20 | Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study显示文摘 | Gurbel PA Bliden KP Butler K | 2010 | Circulation2010，121，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员